Fischer Medical Ventures Ltd

Stage 4 · Declining · week 9

As of 20 Nov 2026, Fischer Medical Ventures is in Stage 4, the downtrend phase, now in week 9 (since 17 Sep 2026). It closed at ₹22.33, 62.0% below its 52-week high and below its 200-day average, which is falling. In Health Care, 34.7% of stocks are in Stage 2.

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. More about the company

₹22.3
Close, 20 Nov 2026
-2.32% on the day
₹1,560 Cr · Small cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dHealth Care Equipment & Supplies 0.0%-20.0 pts

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

RS rank

Edge

—

FISCHER is in a decline, 37% below its 200-day average. Declining stocks have lagged the market more than any other group; we wait for a base before looking again.

Its relative strength is 2 of 99, below the middle among NSE stocks over the past year. Health Care Equipment & Supplies ranks 45 of 106 industries by the strength of its stocks.

Is FISCHER early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2025-07-10 → 2026-11-20
S? 42w
S4 11w
S1 8w
S4 9w
2025-07-102026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S1 1w → S4 11w → S1 8w → S4 9w current
Total tracked: 71 weeks across 5 stage runs.

FISCHER among Health Care Equipment & Supplies8th of 11 by relative strength

All 11 →
Stocks in Health Care Equipment & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1UNIVPHOTOStage 3 · wk 495+4.4%
2TARSONSStage 3 · wk 382+1.1%
3IKSStage 3 · wk 867+0.6%
4BALAXIStage 4 · wk 1949+59.1%
5POLYMEDStage 3 · wk 546+11.3%
6BOROSCIStage 4 · wk 645+5.3%
7LAXMIDENTLStage 4 · wk 1414+5.4%
8FISCHERStage 4 · wk 92−11.1%
vs 52W High
-62.0%
₹22.3 lo₹58.8 hi
62.0% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 9
1w13w26w
Week 9, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-37.3%
200 DMA: ₹35.6 · sloping down
The stock is below its 200-day average, the mark of a downtrend. Stage analysis waits for the price to reclaim that line.
Rel Volume
0.21x
vs 50-day avg
Volume was well below average. Quiet sessions are common in a Stage 4 decline, and a low-volume bounce is easy to mistake for a reversal.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-11.1%
3M
-42.7%
6M
-36.3%
YTD
-46.3%
1Y
-65.8%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
Sector has 58 Stage 2 leaders. See Health Care Stage 2 →
Industry
Health Care Equipment & Supplies
↓ Peaking
Stage 2%
0.0%
20d Δ
-20.0pp
1M return
+6.1%
3M return
-0.8%
Industry Stage-2 % · last 20 days

Mutual fund holdings

Held by 4 mutual funds in portfolios to October 2026: 0 active funds and 4 index funds and ETFs.

In October, no active fund changed its holding.

All 4 funds and what each did in October

Mutual funds holding FISCHER: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Recent Stage Timeline
2026-11-20S4
Wk 9 · Vol 0.21x
2026-11-19S4
Wk 9 · Vol 0.30x
2026-11-18S4
Wk 9 · Vol 2.13x
2026-11-17S4
Wk 9 · Vol 0.66x
2026-11-16S4
Wk 8 · Vol 0.72x
2026-11-13S4
Wk 8 · Vol 0.35x
2026-11-12S4
Wk 8 · Vol 0.34x
2026-11-11S4
Wk 8 · Vol 1.05x
2026-11-09S4
Wk 8 · Vol 0.26x
2026-11-06S4
Wk 7 · Vol 0.49x
2026-11-05S4
Wk 7 · Vol 0.51x
2026-11-04S4
Wk 7 · Vol 2.48x
Moving averages & range
50 DMA
₹29.2
200 DMA
₹35.6
52W High
₹58.8
52W Low
₹22.3
5D Low
₹22.3
Resistance levels (recent highs)
20d High
₹27
60d High
₹37.7
120d High
₹41.7
250d High
₹49.6
Next resistance
+20.9%
to 20d High
P/E (TTM)
10.6
Forward —
Dividend Yield
0.20%
P/B 4.2

Fischer Medical Ventures: quick answers

What stage is Fischer Medical Ventures in?

As of 20 Nov 2026, Fischer Medical Ventures (FISCHER) is in Stage 4, the downtrend phase. It entered Stage 4 on 17 Sep 2026 and is in week 9. What the four stages mean

Is Fischer Medical Ventures in an uptrend?

No. Fischer Medical Ventures is in a Stage 4 downtrend. It trades 37.3% below its 200-day average, which is falling.

How far is Fischer Medical Ventures from its 52-week high?

Fischer Medical Ventures closed at ₹22.33 on 20 Nov 2026, 62.0% below its 52-week high of ₹58.75. Its 52-week low is ₹22.33.

How has Fischer Medical Ventures performed over the past year?

As of 20 Nov 2026, Fischer Medical Ventures is down 65.8% over the past year and down 46.3% so far in 2026.

Which sector and industry is Fischer Medical Ventures in?

Fischer Medical Ventures is in the Health Care Equipment & Supplies industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Health Care

About this companyHealth Care· Health Care Equipment & Supplies

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.